What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Mar 17, 2025 - 13:42
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Read More

Tags:

Previous Article

Workshop managers share concerns over potential MOT recall rule change

Next Article

Health Canada approves RetinaLogik’s VR visual exam platform

Related Posts

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 10:00 (CET) to 19 November 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Xydalba, dalbavancin hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0467/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0

List of medicines currently in PRIME scheme

Feb 9, 2025  0